PRF Technologies (PRFX) Cash from Financing Activities (2020 - 2023)

PRF Technologies (PRFX) recorded quarterly Cash from Financing Activities of $1.0 million in Q4 2023, down 71.56% on a QoQ basis from $3.6 million in Q3 2023.

PRF Technologies (PRFX) Cash from Financing Activities (2020 - 2023) Analysis & Trends

PRF Technologies has disclosed Cash from Financing Activities across 3 years of filings, most recently posting $1.0 million for Q4 2023.

  • Quarterly Cash from Financing Activities changed N/A year-over-year to $1.0 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $6.5 million (changed N/A YoY) and the FY2025 annual result came in at $3.8 million, down 56.92% from the prior year.
  • Cash from Financing Activities retreated to $1.0 million in Q4 2023, from $3.6 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $7.5 billion in Q3 2021 and troughed at -$7.5 billion in Q4 2021.
  • A 3-year average of $4.9 million and a median of $4.6 million in 2021 frame the typical range for Cash from Financing Activities.
  • Biggest YoY gain for Cash from Financing Activities was 42899.34% in 2021; the steepest drop was 42899.34% in 2021.
  • Tracing PRFX's Cash from Financing Activities over 3 years: stood at $17.4 million in 2020, then slumped by 43088.25% to -$7.5 billion in 2021, then surged by 100.01% to $1.0 million in 2023.
  • Business Quant data shows PRFX's Cash from Financing Activities at $1.0 million in Q4 2023, $3.6 million in Q3 2023, and -$7.5 billion in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 13.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -840.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -1.48 Bn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -86.10 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -65.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 1.47 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -77.88 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -11.62 Mn
10 PRF Technologies 933,081.16 -2.46 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2023 1.02 Mn
Dec 31, 2023 1.02 Mn
Sep 30, 2023 3.59 Mn
Sep 30, 2023 3.59 Mn
Dec 31, 2021 -7.48 Bn
Dec 31, 2021 -7.48 Bn
Sep 30, 2021 7.48 Bn
Sep 30, 2021 7.48 Bn
Mar 31, 2021 5.55 Mn
Mar 31, 2021 5.55 Mn
Sep 30, 2020 17.39 Mn
Sep 30, 2020 17.39 Mn